Iron-isomaltoside-1000Pruritus and rash: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1709卷 / 1期

关键词：

D O I：

10.1007/s40278-018-48543-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：132 / 132

相关论文

共 50 条

[21] Ipilimumab/nivolumabBell's palsy, rash and pruritus: case report
Reactions Weekly, 2018, 1684 (1) : 140 - 140
[22] Multiple drugsLack of efficacy, mild pruritus and rash: case report
Reactions Weekly, 2025, 2044 (1) : 227 - 227
[23] Multiple drugsLack of efficacy and sporadic rash with pruritus: case report
Reactions Weekly, 2023, 1945 (1) : 363 - 363
[24] TozinameranSkin rash, cervicofacial pruritus and cervicofacial oedema: case report
Reactions Weekly, 2024, 2027 (1) : 473 - 473
[25] Intravenous iron isomaltoside (Monofer)-induced hypophosphataemia: a case report
Wong, K. Y.
Yu, K. Y.
Mak, M. W. H.
Lee, K. M.
Lee, K. F.
HONG KONG MEDICAL JOURNAL, 2022, 28 (03) : 267 - 269
[26] Alectinib/ensartinibAcquired resistance in lung adenocarcinoma, rash and pruritus: case report
Reactions Weekly, 2023, 1950 (1) : 23 - 23
[27] Carboplatin/gemcitabine/pembrolizumabLack of efficacy, pruritus and skin rash: case report
Reactions Weekly, 2022, 1913 (1) : 131 - 131
[28] Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease
Nordfjeld, Kim
Andreasen, Hans
Thomsen, Lars L.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 : 43 - 51
[29] A case of generalized pruritus without rash
Puchner, TC
Fink, JN
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 85 (06) : 448 - 454
[30] Ferric-carboxymaltose/iron-isomaltoside-1000Anaphylactic reaction: 2 case reports
Reactions Weekly, 2019, 1750 (1) : 124 - 124

← 1 2 3 4 5 →